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BPC - body protection compound
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PGE2 - prostaglandin E2
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71. GENERAL INTRODUCTION
1.1. GASTRIC CYTOPROTECTION
1.1.1. General aspects
Peptic ulcer is a widely spread disease in the world. The main place of its 
development is the upper gastrointestinal tract, where in natural conditions very 
aggressive compounds can be found (e.g. pepsin and hydrochloric acid). In 
healthy relationships these aggressive factors cannot necrotize the surface 
epithelium, because they are in equipment with the protective agents (Table 1.)
The main curative way to prevent and heal the peptic ulceration was the 
decrease or inhibition of gastric acid secretion. At the end of 1970's a new field 
appeared in the experimental ulcer research, namely the protective side. In 1978 
Chaudhury and Jacobson described firstly the term of cytoprotection (Chaudhury 
and Jacobson, 1978).
Table 1
Endogenous defensive and aggressive factors in the pathogenesis of peptic 
ulcer disease.
DEFENCE AGGRESSION
Mucus
Prostaglandins
Bicarbonate
Sulfhydryls
lnterleukin-1
Superoxide dismutase
Catalase
Nitric oxide
Dopamine
Hydrochloric acid
Pepsin
Gastrin
Free radicals
Proteases
Leukotrienes
Helicobacter pylori
Impaired blood flow
Dysmotility
8Cytoprotection was internationally accepted after Robert's publication in 
1979: the gastric mucosa was protected against necrotizing agents (alcohol, HCI, 
NaOH, hypertonic NaCI and thermal injury) by exogenous prostaglandins without 
any inhibition of gastric acid secretion (Robert et al., 1979). This publication gave 
a new impulse and field for the experimental ulcer research, the quickly beginning 
experiments described more and more new cytoprotective drugs. These results 
were published in several books (Recent Advances in Gastrointestinal 
Cytoprotection, 1984; Advances in Gastrointestinal Cytoprotection: Topics 1987, 
1989; Cell Injury and Protection in the Gastrointestinal Tract: From Basic Sciences 
to Clinical Perspectives, 1993; Twenty Five Years of Peptic Ulcer Research in 
Hungary: From Basic Sciences to Clinical Practice (1971-1995), 1997).
There are a lot of mechanisms involved in the phenomenon of gastric 
cytoprotection. In the following chapters the wide range of organ factors will be 
overviewed which also play an important role in the development of gastric 
cytoprotection as the protective or aggressive side.
1.1.1.1. The role o f central nervous system
The brain and the gastrointestinal tract are in a strong connection as the 
parts of the brain-gut axis. Clinical observations verified that affective or emotional 
state influences the gastrointestinal function (Schindler and Ramchandari, 1991). 
In patients with ulcer disease stress and anxiety are associated with the active 
ulcer phase (Feldman et al., 1986). In addition, acute gastric mucosal lesions are 
serious complications of different type of stress situations e.g. burning, trauma or 
infection. Stress ulcer can be used as experimental ulcer model in cytoprotective 
investigations (Kitajima et al., 1989; Toth, 1989).
9In 1965 Strang reported a high incidence of gastroduodenal ulcer disease 
in patients with Parkinson's disease, which is related to a central dopamine 
deficiency (Strang, 1965). Szabo began the systematic study of a role for 
dopamine in duodenal ulcer disease, and proved the significant pathogenetic role 
for dopamine depletion in the genesis of experimental ulcer models (Szabo, 1979; 
Szabo et al., 1982). In addition, there was experimental evidence for a selective 
dopamine neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- 
induced massive nigrostriatal dopamine loss and duodenal ulcers in rats (Szabo et 
al., 1985a).
Dopamine agonist and promoters (L-dopa, bromocriptine, apomorphine and 
D-amphetamine) reduce, while dopamine antagonists (haloperidol, pimozide, 
domperidone) worsen gastric lesions produced by restraint-cold stress (Glavin and 
Dugani, 1987). Dopamine also has a significant role as an endogenous 
gastroprotective agent, especially in adaptive cytoprotection (MacNaughton and 
Wallace, 1989).
These samples are only a part of the role of central nervous system in the 
phenomenon of gastric cytoprotection, there are many other mechanisms involving 
in the regulation of brain-gut axis.
1.1.1.2. The vagal nerve
Almost the whole gastrointestinal tract (from the stomach to the first part of 
large bowel) is innervated by the vagal nerve. In physiological circumstances it 
plays an important role among others in the regulation of gastrointestinal motility 
and secretion of digestive juices.
In addition, the role of vagal nerve in the phenomenon of cytoprotection 
was independently proved by Mozsik and Miller in the early 80s: after bilateral 
surgical vagotomy the prostaglandin-induced protection and adaptive 
cytoprotection were failured (Mozsik et al., 1982; Miller et al., 1983).
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The exact mechanisms of the role of vagal nerve in gastric mucosal 
protection are unknown, but some pathways can be suggested based on 
experimental results:
- Decreased gastric emptying (Mozsik et al., 1992a);
- Decreased synthesis of prostaglandins (Bodis et al., 1990);
- Increased vascular permeability (Kiraly et al., 1990; Mozsik et al., 1993a; Karadi
et al., 1994);
- Changes in the gastric mucosal protective properties of SH-groups (Mozsik et al.,
1990);
- Changes in biochemical mechanisms (Mozsik et al., 1992b);
- Changes in the regulatory mechanisms between the membrane-bound ATP-
dependent energy systems (Vincze et al., 1993);
- Significantly altered regulatory pathways to protective agents (Mozsik et al.,
1995b).
These results emphasize that the vagal nerve has an important role both in 
the development of gastric mucosal damage (by increasing aggressive factors) as 
well as in the development of gastric cytoprotection.
1.1.1.3. B lood flow  and m icrocirculatory changes
The intact blood flow is basically necessary for the maintenance of gastric 
mucosal integrity. Most of the cell and tissue injury is produced by hypoxia, 
especially ischemia due to impaired blood flow. Hypoxia might cause reversible or 
irreversible cell injury. In addition, the reestablished blood flow often aggravates 
the damage because of generation of free radicals (Szabo and Nagy, 1992).
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The changes in blood flow are not only alterations of neural and metabolic 
control but are the result of prior damage to the vascular endothelium. The acute 
mucosal damage in the stomach is manifested as a hemorrhagic lesion. Vascular 
injury is a very early event in the pathogenesis of chemically induced gastric 
erosions (Szabo et al., 1985b). Lacy and Ito microscopically analyzed the changes 
in gastric mucosa during cytoprotection induced by prostaglandins, and reported 
that only the hemorrhage and not the surface epithelial lesions was prevented 
(Lacy and Ito, 1984). Further studies showed that cytoprotective prostaglandins 
and sulfhydryls preserved the microvascular injury (Szabo, 1984), and they 
maintained blood flow in subepithelial capillaries after topical administration of 
necrotizing agents^Pihan et al., 1986).
The changes in gastric mucosal blood flow are also regulated by neural 
and hormonal influence, and these effects are important in the development of 
gastric cytoprotection. It is mostly mediated by the local release of vasodilatator 
peptides (e.g. tachykinin and calcitonin gene related peptide, CGRP) contained in 
sensory nerve endings (Holzer et al., 1991). Topical administration of capsaicin 
evokes the release of neuropeptides and causes a long-lasting enhancement in 
the microcirculation of the rat stomach and jejunum. It is not mediated through 
vagal or sympathetic pathways, only by stimulation of capsaicin sensitive sensory 
nerves (Abdel-Salam et al., 1996).
These mechanisms represent only a part but underline the important role of 
the vascular compound in the development of gastric cytoprotection.
1.1.1.4. Mucosal barrier
The intraluminal surface of the stomach is covered with mucus layer. This is 
a protective agent against the aggressive factors such as hydrochloric acid and 
pepsin presented in physiological conditions the lumen of the stomach. 
Gastrointestinal mucus occurs as a stable, water-insoluble gel adherent to the
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mucosal surface. It has a variable thickness, about 50-450 [jm (median 180 (jm) in 
man (Kerss et al., 1982).
The most important function of the mucus in the stomach and duodenum is 
the protection of the mucosa. It supports the neutralization of H+ by mucosal HCO3’ 
thus establishing a pH gradient from an acid pH in the lumen to a near neutral pH 
at the mucosal surface (Flemstrom and Gamer, 1982). In addition, the adherent 
mucus gel protects the mucosa from proteolytic attack of intraluminal pepsin. 
Pepsin in the gastric lumen progressively digests the mucus layer, but the loss is 
replaced by secretion of new mucus. This dynamic balance can be damaged 
following exposure to excess pepsin and acid but not acid alone (Leonard and 
Allen, 1986).
It must be point out that the adherent mucus gel layer is not a diffusion 
barrier to necrotizing agents used in cytoprotective investigations such as bile 
salts, hypertonic saline, ethanol and nonsteroidal antiinflammatory drugs (Matuz, 
1992).
1.1.1.5. N itric oxide and gastric mucosal protection
In 1987, it was shown that vascular endothelial cells could synthesize nitric 
oxide (NO), and this gas acted as a labile humoral-like messenger that relaxed 
vascular smooth muscle (Palmer et al., 1987). NO is a colorless gas that is slightly 
soluble in water. In biologic systems NO has a half-life of <5 seconds. Vascular 
endothelial cells synthesize NO enzymatically from L-arginine (Palmer et al., 
1988). In humans NO is formed in both arteries and veins and contributes to the 
control of basal and stimulated regional blood flow (Vallance et al., 1989a; 
Vallance et al, 1989b). Endothelium-derived NO can also diffuse into nearby 
adhering platelets in the lumen of the blood vessels to inhibit platelet adhesion and 
aggregation (Radomski et al., 1987).
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Regarding to these facts, NO also has to play a role in gastric 
cytoprotection altering the mucosal blood flow and platelet aggregation. Several 
experimental results can suppose this hypothesis. Topical mucosal application of a 
NO solution or of glyceryl trinitrate or nitroprusside reduces the severity of ethanol- 
induced hemorrhagic mucosal damage (MacNaughton et al., 1989). Intravenous 
administration of nitroprusside also inhibits mucosal damage (Wallace et al., 
1989a). Administration of inhibitors of NO synthesis alone did not lead to acute 
gastric mucosal damage in the rat. However, inhibition of NO synthesis after 
depletion of vasodilator neuropeptides with chronic capsaicin pretreatment or after 
inhibition of prostacyclin synthesis with indomethacin did induce substantial 
mucosal injury (Whittle et al., 1990).
In pathological circumstances the development of mucosal ulceration could 
be related to decreased endothelial production of vasoactive mediators with 
protective actions such as NO. In pharmacological point of view an increased 
mucosal level of NO could be protective against gastric mucosal injury in high risk 
patients.
1.1.1.6. Prostaglandins and nonsteroidal antiinflam m atory drugs
Nonsteroidal antiinflammatory drugs (NSAIDs) are commonly used for 
rheumatic disorders, fever, pain and inflammation. Generally these drugs are well 
tolerated, but in a significant minority gastrointestinal side effects may result in 
serious complications. The main action of NSAIDs is inhibiting cyclooxigenase 
enzyme activity and by this way decreasing the synthesis of novel inflammatory 
mediators, namely prostaglandins (Vane, 1971).
Inflammation is the response of living tissues to injury. It involves a complex 
array of enzyme activation, mediator release, extravasation of fluid, cell migration, 
tissue breakdown and repair. Prostaglandin E2 is the predominant eicosanoid
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detected in inflammatory conditions. Prostaglandins belong to a class of 
polyunsaturated fatty acids derived from arachidonic acid, a phospholipid 
component present in all cell membrane. Arachidonic acid is released from the cell 
membrane into the cytoplasm by phospholipase A2 and is converted to 
prostaglandins or leukotrienes by the enzymes cyclooxigenase and 5- 
lipoxigenase, respectively. Prostaglandins are tissue specific, in the 
gastrointestinal mucosa PGE2, PGb and PGF2«iph» are the most prevalent 
eicosanoids. Prostaglandins inhibit gastric acid secretion endogenously in the 
stomach, and in a high dose exogenously. They have also an important role in 
gastrointestinal mucosal defense like a cytoprotective agent (Robert et al., 1979).
Recently two types of cyclooxigenase have been identified: COX-1 and 
COX-2. Both enzymes have a similar molecular weight and active sites for the 
attachment of arachidonic acid or NSAIDs, although the active site on COX-2 is 
larger and can accept a wider range of structures as substrates (Vane and 
Botting., 1995).
COX-1 is constitutively expressed in most tissues, and performs a 
"housekeeping" function to synthesize prostaglandins which regulate normal cell 
activity. The concentration of the enzyme is stable, but small increases can occur 
in response to stimulation with hormones or growth factors (DeWitt, 1991). Little or 
no COX-2 is found in resting cells but its expression can be largely increased after 
exposure of cells to bacterial lipopolysaccharide, phorbol esters, cytokines or 
growth factors. COX-2 can be produced in many cells and tissues and its induction 
inhibited by glucocorticoids such as dexamethasone (Masferrer et al., 1990).
NSAIDs are the potent inhibitors of cyclooxigenase enzyme, and the 
differences in action and side effects of different drugs can be explain by their 
different activity on COX-1 and COX-2. Piroxicam 250, aspirin 166 and 
indomethacin 60 times more active on COX-1 than COX-2, but some compounds 
e.g. meloxicam, naproxen and diclofenac are good selective inhibitors of COX-2 
(Vane and Botting, 1995). The pharmacological profiles of COX-1 and COX-2 are 
different, so it will be possible to develop new antiinflammatory drugs which are 
specific inhibitors of COX-2 and will not have gastrointestinal side effects.
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1.1.1.7. A  new aggressive factor: Helicobacter pylori
Nowadays Helicobacter pylori (H. pylori) is one of the most frequent field in 
gastroenterology. This bacterium was firstly isolated from a patient with chronic 
gastritis in 1983 (Warren, 1983), and since then it has been linked to 
gastrointestinal diseases in human. Epidemiological studies proved the presence 
of this bacterium in biopsy samples from patients suffering gastritis, gastric and 
duodenal ulceration (Taylor et al., 1991; Moss et al., 1992). In addition, there is a 
doubt that H. pylori is in connection with gastric carcinoma and lymphoma (Loffeld 
et al., 1990).
How does this bacterium cause gastrointestinal diseases? There are many 
explanations to this question. Some papers emphasized the direct cellular effect of 
bacterial toxins (Figura et al., 1994), the breakdown of the mucus layer (Sarosiek 
et al., 1994), the role of H. pylori exotoxins includes urease, which catalyses the 
production of ammonia (Nagy et al., 1996), proteases, phospholipase A2 and 
platelet-activating factor (Wyle et al., 1993), and the interactions between the 
bacterial unusual fatty acids and gastric parietal cells (Beil et al., 1994).
W hile H. pylori persists in a living organism, the host's immune system has 
to play an important role in inflammation, and immune reactions can lead to 
development of cell injury. In the last century Robert Koch described his four 
principles for acceptance of the infectious origin of different diseases (Jawetz et 
al., 1982), namely 1. microorganism must regularly be isolated from the caches of 
the illness; 2. it must be grown in pure culture in vitro; 3. when such a pure culture 
is inoculated into susceptible animal species, the typical disease must be resulted; 
and 4. microorganism must be again isolated from the tissues of experimentally 
induced disease. Koch's principles also exist in our days for the acceptance of a 
possible factor as an infectional aetiology for a disease. The first, second and 
fourth principle can be proved in different observations, however, in the case of H. 
pylori all criteria never were proved together neither in humans nor in experimental 
circumstances (Graham, 1995; Ross et al., 1992). Marshall's observations (when 
he drank a broth of H. pylori) (Marshall et al., 1985) clearly indicated that H. pylori
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(at least alone) cannot cause peptic ulcer. The endoscopic studies at the 10th day 
after the infection proved the development of gastritis (without appearance of 
gastric and duodenal ulcer), which disappeared before 14 days. One possible 
conclusion of Marshall's observations is that H. pylori might produce gastritis, 
however, it cannot produce gastroduodenal ulcer in humans.
Koch's third postulate was not proved until now, namely there is no 
experimental model in which the cultured H. pylori can produce peptic ulcer (or 
only gastroduodenal ulcer). It was impossible to induce gastritis in rats by feeding 
H. pylori suspensions for seven days period, however, the presence of H. pylori 
was demonstrated in the gastric mucosa (Ross et al., 1992).
The question remains open about a pathogenetic or opportunist role of H.
■ *
pylori in the aetiology of peptic ulcer and low grade gastric lymphomas. The 
intensive experimental and clinical observations might answer these problems and 
clear up the exact role of H. pylori in human diseases.
1.1.1.8. Free radicals and scavenger com pounds
Free radicals are well known common pathways in cellular injury due to 
lipid peroxidation and membrane damage (in details see chapter 2.1.1.). In the 
living organisms it can be manifested among others as a tissue necrosis or as a 
genetic malformation e.g. development of malignancies.
During gastrointestinal mucosal damage the necrotizing agents induce an 
expressive free radical formation. Its possible role was suggested by the fact that 
some scavenger compound has cytoprotective properties (Javor et al., 1986). In 
addition, gastric mucosa contains a high level of glutathione, which is able to 
protect the cells against free radicals (Boyd et al., 1979).
The scavenger compounds-induced gastric cytoprotection is manifested in 
about 15-60 min after administration of necrotizing agents (Vincze et al., 1991a). 
This observation shows that in the gastric mucosa the primary event is the direct 
cellular and tissue damage, and this effect induces a free radical formation, which 
can be protected by scavengers.
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Carotenoids are widely used cytoprotective agents in gastrointestinal 
observations. Besides their scavenger properties, a wide range of retinoids have 
vitamin A activity which can promote the epithelial restitution and ulcer healing 
(Mozsik et al., 1993b). It could be another explanation for the action in the later 
phase of tissue injury.
Regarding to these facts cytoprotection induced by scavenger compounds 
is a very complex and multifactorial phenomenon.
1.2. IN VIVO ORGANOPROTECTION
1.2.1. Experim ental results
The aim of the next chapters is to summarize the main approaches of a part 
of in vivo observations carried out in animal models. These results represent the 
mechanisms of organoprotection usually in rats. The effects induced by 
necrotizing agents and organoprotective factors are very complex and 
multifactorial events, it is impossible to decide whether organo- or cytoprotection is 
more important in the development of the beneficial results.
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1.2.1.1. Prostaglandins and prostacyclin
In 1979 prostaglandins (PGs), namely 16,16-dimethyl PGE2 was firstly 
described as a cytoprotective agent (Robert et al., 1979). The effect of PGs is a 
very complex mechanisms. After bilateral surgical vagotomy the protective effect 
induced by PGs is failured (Mozsik et al., 1982), and the stimulation of the vagal 
nerve enhances the tissue formation and release of gastric mucosal PGs (Singh, 
1980).
On the other hand, other compounds e.g. sulfhydryls are also necessary for 
the gastroprotective effect of PGs (Johansson and Bergstrom, 1982).
The PGs-induced protection manifests in the early phase after 
administration of necrotizing agents (Suto et al., 1989), this is the phase of the 
early vascular and mucosal injury (Szabo et al., 1985b). Microscopic studies 
showed that initially only the deep hemorrhagic lesions is prevented by PGs (Lacy 
and Ito, 1984). It seems that one of the main function of these compounds is the 
maintenance of subepithelial blood flow (Szabo and Pihan, 1987).
According to these facts PGs-induced gastric protection is originated from 
many mechanisms. Further experiments are required at cellular level to assess the 
direct cellular events of this phenomenon.
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1.2.1.2. H istam ine and pentagastrin
Histamine and pentagastrin are novel aggressive factors in the stomach 
due to stimulation gastric acid secretion. The cellular mechanisms involved in the 
gastric acid secretion of rats in ethanol-induced mucosal damage and prostacyclin 
(PGbJ-induced gastric cytoprotection have been studied: atropine, adrenalin, 
cimetidine, prostacyclin, actinomycin D, Degranol (mannomustine) inhibited the 
gastric acid secretion and ethanol-induced mucosal damage (Mozsik et al., 1982), 
while surprisingly histamine, pentagastrin and 2,4-dinitrophenol (which enhanced 
the gastric acid secretion in a short time period) stimulated the PGh-induced 
gastric cytoprotection (Mozsik et al., 1995a; Bodis et al., 1996a; Bodis et al., 
1997a). So the drugs stimulating the aggressive side (HCI) of the stomach, could 
enhance the PGh-induced gastric cytoprotection. Furthermore, it was proved that 
the intact vagus is basically necessary for the receiving gastric cyto- and mucosal 
protection by atropine, cimetidine, PGh and (3-carotene (Mozsik et al., 1995a).
What can be suggested as the biochemical background of the in vivo 
cytoprotective effects of these aggressive drugs? The inhibitory drugs such as 
cimetidine and atropine decrease the cell metabolism, while pentagastrin, 
histamine and 2,4-dinitrophenol (for a short time) increase it. The PGh-induced 
gastric cytoprotection is decreased by gastric acid inhibitory drugs, however, 
histamine, pentagastrin and 2,4-dinitrophenol can stimulate it. This effect partly 
can be explained by acting at the level of receptors due to reduction of ATP-ADP 
transformation and increasing the cellular cAMP content (in the case of histamine 
and pentagastrin) (Mozsik et al., 1988), but the mechanism of 2,4-dinitrophenol is 
quite different (inhibition the respiratory chain). W ith this knowledge of the facts 
metabolic components have to play a role in the protection of gastric mucosal 
damage.
However, further observations are required at the level of the cells to 
decide whether organo- or cytoprotection takes a part in the histamine- and 
pentagastrin-induced gastric mucosal protection.
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1.2.1.3. Scavenger com pounds
Some compounds, namely retinoids (vitamin A, beta-carotene, beta- 
cryptoxanthin, zeaxanthin) have scavengers property besides their cytoprotective 
effect (Javor et al., 1986). The possible role of oxygen free radicals in gastric 
mucosal lesions was also based on this observation. The gastric cytoprotection is 
not depended on presence of vitamin A activity, beta-ionone ring, number of 
unsaturated links and chemical structure of terminal part of molecules (Mozsik et 
Javor, 1991).
Beta-carotene is one of the widely used scavengers in cytoprotective 
investigations. It did not decrease the gastric secretory response in pylorus-ligated 
rats, but it was able to prevent the gastric mucosal damage induced by ethanol, 
hydrochloric acid or indomethacin (Mozsik et al., 1991a). One of the possible 
explanation of the beneficial effect of beta-carotene is based on its scavenger 
property. It was proved that free radicals play a role in ethanol-induced mucosal 
damage (Pihan et al., 1987), but it is only a part of the action of beta-carotene. 
However, the intact vagal nerve and adrenals are basically necessary for the 
development of beta-carotene-induced gastric mucosal protection. In addition, this 
process is not mediated by prostaglandins, and might be partly mediated by SH- 
groups (Vincze et al., 1997). Time course studies proved that the action of 
scavengers manifested only at later phase of mucosal damage despite with 
prostaglandins (Vincze et al., 1991).
It seems that there are many factors presenting the scavengers-induced 
organoprotection, among others there must be direct cytoprotective effect due to 
elimination of free radicals.
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1.2.1.4. Body protection com pound, BPC
A new human gastric juice peptide (code-named body protection compound 
- BPC, M.W. 40.000) was isolated by Sikiric et al., which is generally described as 
an organoprotective agent (Sikiric et al., 1991a,b; Mozsik et al., 1991b). In 
experimental models it has beneficial effect among others on the gastrointestinal 
tract (stomach, pancreas, small and large intestine), kidney, brain, liver. After 
several biochemical procedures a 15 amino acid fragment (BPC 157), though to 
be essential for the activity of entire peptide, was characterized (Sikiric et al., 
1993a). Although the exact mechanisms of this prevention are yet unknown, they 
are probably mediated in adrenal, parathyroid, thyroid and ovarian pathways 
(Sikiric et al., 1992). Recently this natural compound BPC 157 was synthesized 
and named PL-10 substances, which also show the in vivo general protective 
effect (Erceg et al., 1997).
A significant pool of BPC has been immunohistochemically demonstrated in 
the stomach as well as in the brain (Sikiric et al., 1993a). Based on the protective 
effects of different peptides given centrally and/or peripherally, on a relatively short 
halftime, on a small molecule size (15 amino acids) it seems that BPC primary has 
special gut peptide properties. In addition, its role in the induction of the healing 
processes appears to be very likely (Sikiric et al., 1994). Acute toxicology shows a 
very high therapeutic index, since no death or pathologic changes were observed 
despite the administration of a very high dosage (e.g. 50 mg/kg) (Sikiric et al., 
1993a).
The wide range of benefit actions on different organs can be explained only 
by direct cellular effect - by direct cytoprotection. Regarding to these facts, after 
further investigations BPC also might have a part in human therapeutics as an 
antiulcer drugs.
22
2. CYTOPROTECTION OR ORGANOPROTECTION?
In the early 80s some research teams suggested that the terminology of 
"organoprotection" is more suitable for the phenomenon of cytoprotection. The 
word "gastric cytoprotection" originally means the protection of gastric mucosal 
cells, but in vivo experiments many other factors e.g. central nervous system 
(Grijalva et al., 1990), vagal nerve (M6zsik et al., 1993a), blood flow (Szabo et al., 
1985b; Guth et al., 1984), vascular permeability (Szabo et al., 1985b) and the 
rapid epithelial restitution from surviving neck cells (Lacy and Ito, 1984) play an 
important role in the mechanisms of defence. On the other hand, cytoprotection is 
not a general phenomenon: the protective effects are not the same in different 
models, and it is not general in different parts of the gastrointestinal tract.
Regarding to these facts the terms of organoprotection and cytoprotection 
differ from each other. Organoprotection is a complex phenomenon, it consists 
many other factors from other organ systems e.g. vascular, hormonal and neural 
effects, while cytoprotection means the direct cellular events induced by toxic 
agents or drugs.
New methods are required for the complex analysis of cytoprotection to 
study the direct cellular effect of the in vivo organoprotective agents. There are two 
possibilities for in vitro observations: freshly isolated cells (short term culture) and 
cell lines (long term culture). In the following chapters the mechanisms of cell 
injury, the advantages and disadvantages of these two kind of cell cultures will be 
overviewed.
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2.1. CYTOPROTECTION AT CELLULAR LEVEL
2.1.1. The mechanism s o f cell in jury
Cell injury (reversible or irreversible) occurs as a result of single or multiple 
causes, and it develops through multiple steps and pathways. These pathways are 
mostly nonspecific: ischemic, chemical or physical factors induce same or similar 
manifestations.
The five common causes of cell injury are:
1. Hypoxia and ischemia
a. Decreased blood supply
b. Decreased 02-carrying capacity
c. Diminished tissue oxidative enzymes
2. Chemicals
a. Natural (e.g. aflatoxin) vs. synthetic
b. Water vs. lipid solubility
3. Biologic agents
a. Viruses, rickettsiae, bacteria, fungi, parasites
b. Immunological reactions
4. Physical factors - usually irreversible cell injury
a. Mechanical force e.g. trauma, pressure
b. Temperature extremes: bum, frost-bite
c. Electric shock
d. Ionizing radiations
5. Genetic defects - slowly developing
a. Chromosomes (autosomes or sex chromosomes)
b. Plasma membrane regulating receptors or transport processes
c. Enzymes regulating catabolism or anabolism
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Although there is no common final pathway of cell injury and death, a few 
common chemical entities should be considered. One of them is the free radical 
activity. These activated oxygen species and free radicals have very short half 
lives but are extremely reactive damaging to the environment where they are 
generated. The main mechanism of injury caused by free radicals is lipid 
peroxidation which destruates the polyunsaturated fatty acids-containing biological 
membranes. The other common pathway of cell injury is the alteration in calcium 
homeostasis. Ischaemia, chemicals or microbiologic agents may influence the 
huge gradient between extracellular and intracellular free calcium concentrations. 
These changes result the poisoning of mitochondrial oxidative processes, 
interference with normal receptor-membrane functions, and possible activation of 
phospholipase A2 which leads to degradation of membrane phospholipids.
The early morphologic changes in cell injury may only be observed by 
electron microscopy. Plasma membrane alterations reflect the disturbances in ion 
and volume regulations induced by loss of ATP. These include cell swelling, 
formation of cytoplasmic blebs, blunting and distortion of microvilli, creation of 
myelin figures, and loosening of intracellular attachments. These changes can 
occur rapidly and are readily reversible. In late stages, breaks are seen in both the 
membranes enclosing the cells and organelles. The irreversible phase of cell 
injury is characterized by the loss of mitochondrial and membrane functions.
Cell and tissue injury in the gastrointestinal mucosa is also a very complex 
phenomenon. In addition to the direct toxic effect of a drug, one has to take into 
consideration an ischemic component and a role of vascular injury as well as the 
damaging action of acid and pepsin that are normally present in the lumen of the 
upper gastrointestinal tract. In the other hand it is possible to preserve most of the 
structure and function of a tissue and an organ despite the fact that thousands of 
cells might be killed. However, it is important to underline the differences between 
cell and tissue injury: cells might be sacrificed while the tissue structure and 
function are not markedly altered - they might actually be "protected". The 
differences between cytoprotection and organoprotection are also based on this 
fact.
25
2.1.2. Short term  and long term  cell culture system s
The new exact way in the complex analysis of cytoprotection is the studies 
on freshly isolated cells (short term culture) or on primary/continuous (long term) 
cultures. By this way all of the surrounding effects originated from other organs 
can be eliminated, and the behavior of the single cells can be examined. These 
methods are suitable for direct cytoprotective investigations.
In the analysis of gastrointestinal cytoprotection cell isolation can be 
performed from the stomach (usually from the rats, because in vivo investigations 
were carried out also on these animals). The other advantage of the cell isolation 
is that one study requires only one or two rats. The animals are anesthetized and 
killed without any painful procedures.
Gastric mucosa is consists of several cell types. The luminal surface is 
lined with surface mucous cells, in the glandular regions mucous neck cells, chief 
cells, parietal cells, endocrine-like cells and undifferentiated cells can be found 
(Fig. 1).
By the help of digestion with enzyme preparations e.g. pronase, 
collagenase mixed population of gastric mucosal cells can be isolated (Nagy et al., 
1994). In a short term culture the life time of the cells is about 6-8 hours, they are 
suitable only for short-term observations. In addition, the surface receptors can be 
damaged during the isolation processes and there is not enough time for 
regeneration. These freshly isolated cells are a good targets for toxicological 
studies, however, their receptors can be stimulated only with pharmacological (not 
physiological) doses of drugs (Nagy et al., 1994).
Fig. 1
Schematic diagram of a gland in the glandular stomach representing the 
different cell types which can be isolated by enzymatic digestion.
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The usage of long term cell cultures in cytoprotective investigations have 
several advantages. Long term cell cultures can be continuous cell lines (usually 
they are malignant cells) or primary cultures from acute isolation and enrichment.
Cell lines are always in the same circumstances, the observations are well 
reproducible, these cells are not influenced by other effects. The experiments can 
be long term studies, the surface receptors are unharmed.
The primary cultures of the cells especially from the stomach are good 
targets for pharmacological observations, for remodelling the different 
physiological regulating pathways and biochemical processes in the cells.
Parietal cells are highly differentiated cells with a finite life span, they can 
be cultured for 1-2 weeks, the cell number in the culture is decreased by 5-10% 
per day (Chew et al., 1989). After isolation parietal cells must be enriched from the 
mixed population. The partially enriched parietal cells are rapidly overgrown with 
mucous-containing and fibroblast-like cells. By the methods of Chew et al. 100% 
purity can be approached. Stimulation by histamine and carbachol induces 
morphological changes in the parietal cells: there is a significant increase in cell 
size and canalicular microvilli are appeared. These events can be blocked by pre­
addition of receptor antagonists (Soroka et al., 1993; Chew, 1994).
The advantages and disadvantages of the different cell culture models are
summarized in Table 2.
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Table 2
Advantages and disadvantages of different types of cell culture models.
1 Advantages Disadvantages
Short term culture Easy methodology Short life time 
Possible receptor damage
Continuous culture Well reproducible 
Long-term studies
Malignant cells
Primary culture Long-term studies Difficult to culture
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2.2. THE AIMS OF THIS STUDY
The aim of this study was to analyze the in vitro effect of some in vivo 
aggressive and protective agents. The in vitro observations were carried out
- on a short term  (freshly isolated gastric mucosal cells from the rats) and
- on a long term  (Sp2/0-Ag14 - a non-secreting mouse myeloma cell line as an
internationally accepted general cell model) cell culture  
"models.
By the help of these cultures the direct cellular effect of the aggressive
factors and agents having in vivo organoprotection were analyzed, namely:
1) Direct short term and long term cellular effect of ethanol;
2) Direct cellular effect of indomethacin without or with application of other 
aggressive factors;
3) Direct cellular effect of the homogenate of human pathogenic Helicobacter 
pylori;
4) The prostacyclin-induced direct cytoprotection against ethanol- and 
indomethacin injury;
5) Direct cellular effect of histamine and pentagastrin;
6) Cytoprotection induced by PL-10 substances (synthesized parts of BPC);
7) The effect of scavengers in long term cell injury.
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3. SHORT TERM CULTURES
3.1. MATERIALS AND METHODS
3.1.1. Preparation o f m ixed gastric m ucosal ce lls from  rats
Gastric mucosal cells (GMCs) from 1-2 unfasted Sprague-Dawley rats were 
isolated by the method of Nagy et al. (Nagy et al, 1994). Briefly, the segments of 
glandular stomach without blood vessels and surrounding connective tissue were 
sequentially incubated in a physiologic solution containing 0.5 mg/ml pronase E 
(type XXV, Sigma Chemical Co., St. Louis, USA) and 10‘3 M EGTA (Sigma 
Chemical Co., St. Louis, USA). After several washing cells were resuspended and 
kept in shaking water bath at 37°C in a solution (0.157 M, pH 7.4) produced 
freshly with the following ingredients (mM): 98.0 NaCI (Reanal, Budapest, 
Hungary), 5.8 KCI (Reanal, Budapest, Hungary), 2.5 NaH2P04 (Reanal, Budapest, 
Hungary), 5.1 Na pyruvate (Reanal, Budapest, Hungary), 6.9 Na fumarate (Sigma 
Chemical Co., St. Louis, USA), 2.0 glutamine (Sigma Chemical Co., St. Louis, 
USA), 24.5 HEPES Na (Sigma Chemical Co., St. Louis, USA), 1.0 Trizma base 
(Reanal, Budapest, Hungary), 11.1 D-glucose (Reanal, Budapest, Hungary), 1.0 
CaCb (Reanal, Budapest, Hungary), 1.0 MgCh (Reanal, Budapest, Hungary) and 
2.0 mg/ml (w/v) bovine serum albumin (Reanal, Budapest, Hungary). Examinations 
were carried out also in this solution. 85-95 % initial viability of the isolated cells 
was maintained for 6-7 h.
Mixed population of freshly isolated gastric mucosal cells contains about 
20-25 % parietal cells and approximately 40-40 % chief and mucous producing 
cells (Fig. 2).
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3.1.2. Determ ination o f cell v iab ility
Cell viability can be determined at different levels of the cells, namely at the 
level of the membrane, at the level of mitochondria and at the level of the nucleus 
(Fig. 3).
Fig. 2
Freshly isolated rat gastric mucosal cells by Congo red staining. The big 
bright red cells are parietal cells, the smaller ones are chief cells, while the 
smaller cells with gray cytoplasm are mucous producing ceils.
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3.1.2.1. Trypan B lue exclusion test
Trypan Blue (TB) is excluded by viable cells, while taken up by damaged 
cells staining the cytoplasm blue (Baur et al, 1975). 0.4 % TB (Sigma Chemical 
Co., St. Louis, USA) was mixed with the same volume of cell suspension and 5 
min later the rate of stained (dead) and unstained (viable) cells were calculated as 
% after counting 100 cells in hemocytometer.
Tubulovesicles
Fig. 3
The levels of cell injury. Membrane damage can be determined by Trypan 
Blue exclusion test and lactate dehydrogenase assay, mitochondrial function 
can be measured by succinic dehydrogenase assay, while nuclear damage 
can be assessed by ethidium bromide-DNA fluorescence method.
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3.1.2.2. B iochem ical assays
3.1.2.2.1. Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) enzyme can be found in the cytoplasm of 
the cells. If it presents in the supernatant, it can indicate the membrane damage of 
the cells. Its actiyity was determined in samples of both toxic agent-free 
supernatant and cell pellet destroyed by freeze. The colorimetric assay was based 
on reduction of NAD+ to NADH catalyzed by LDH in presence of lactate as 
substrate (Bergmeyer and Bern, 1974). The color product of the reduction of 
phenazine metosulphate (Sigma Chemical Co., St. Louis, USA) and tetrazolium 
salt isonicotinic acid hydrazid (Sigma Chemical Co., St. Louis, USA) was 
measured at 520 nm on Hitachi 124 spectrophotometer. The results were 
expressed as mU/min/106 cells.
3.1.2.2.2. Succinic dehydrogenase assay
Succinic dehydrogenase (SDH) enzyme can be found in the mitochondria. 
The mitochondrial integrity was tested in 2x106 previously treated and redispersed 
cells (Mosmann, 1983). The color formazan product was quantified by Hitachi 124 
spectro-photometer at 500 nm and calculated as nmol/min/2x106 cells.
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3.1.2.2.3. E thidium  bromide-DNA fluorescence assay
The nuclear damage of cells was assessed by nuclear fluorescence due to 
the ethidium bromide-DNA binding (Dey and Majumder, 1988). 107 cells were 
mixed with EB solution (Sigma Chemical Co., St. Louis, USA), and the 
fluorescence intensity was measured in Hitachi F-3000 fluorescence 
spectrophotometer at 325-585 nm (excitation-emission). The results were 
expressed as arbitrary fluorescence units/107 cells.
3.1.3. Toxico log ica l studies
3.1.3.1. Ethanol
Cells were incubated with different concentration of ethanol (EtOH) 
(Reanal, Budapest, Hungary) such as 5, 10, 15, 20 and 50% (v/v) for 5 min in 
shaking water bath at 37°C. Equivalent volume of both diluted toxic agent and cell 
suspension were used. At the end of 5 min incubation cells were separated from 
the supernatant by centrifugation (1000 G, 5 min). Cell pellet was carefully 
resuspended and incubated for 10 min in water bath, then it was centrifuged again 
to get the toxic agent-free supernatant and resuspended cells for further 
biochemical assays.
3.1.3.2. Indom ethacin
Cells were incubated with lO^-IO '3 M indomethacin (IND) (Chinoin, 
Hungary) alone or combined with 15% EtOH for 5 min in shaking water bath at 
37 °C. The further processes were the same as described above.
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1.3.3. H elicobacter pylo ri
Helicobacter pylori (H. pylori) was obtained from biopsy samples of patients 
with gastritis, and they were cultured in blood agar base. The existence of infection 
with H. pylori was proven by histology and urease positivity. The bacterial 
suspensions (108 bacteria/ml in 20 mM Tris/HCI buffer, pH 7.0) were sonicated on 
ice (power: 30 W) in six consecutive treatments lasting 30 seconds. Isolated 
GMCs were incubated with sonicated H. pylori (106-108 bacteria/ml) for 30 min in 
shaking water bath at 37°C. At the end of 30 min incubation cells were separated 
from the supernatant by centrifugation, the following examinations were carried out 
as described above.
3.1.4. Pharm acological and cytoprotective investigations
3.1.4.1. Prostacyclin
Cells were preincubated with 1O^-l O'6 M prostacyclin (PGhNa) (Chinoin, 
Hungary) for 60 min in shaking water bath at 37 °C. After this treatment cells were 
incubated with 15% EtOH and 10-3 M IND for 5 min as described above.
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1.4.2. H istam ine
The isolated rat gastric mucosal cells were incubated with 1O^-l O'6 M 
histamine (Peremin, Chinoin, Hungary) for 60 min with or without 10"4 M 
prostacyclin. After this treatment cells were incubated by 15% EtOH alone or 
combined with 10-3 M IND for 5 min. The possible acid secretion was observed by 
measurements of pH in the incubating medium (Radelkis, Hungary).
3.1.4.3. Pentagastrin
Cells were preincubated with 10'8-10'6-10'4 M pentagastrin (Peptavlon, ICI, 
UK) alone or combined with 10-4 M PGb for 60 min in shaking water bath at 37 °C. 
After this treatment cells were incubated with 15% EtOH for 5 min as described 
above.
3.1.4.4. PL-10 substances
PL-10 substances are the synthesized variants of the originally described 
pentadecapeptide BPC 157 (Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly 
Leu Val, M.W. 1419) (Sikiric et al, 1993a). Four compounds were tested dissolved 
in saline:
PL-10.1.AK15-2 - a 15 amino acid compound produced by chemical synthesis 
from the second batch;
PL-10.1.AK15-3 - a 15 amino acid compound produced by chemical synthesis 
from the third batch;
PL-10.1.AK15-4 - a 15 amino acid compound produced by chemical synthesis 
from the fourth batch;
37
PL-10.1.AK14-2 - a 14 amino acid compound produced by chemical synthesis 
from the second batch.
Cells were incubated with 5-50-500 ng/ml-5 pg/ml doses of four PL-10 substances 
(PLIVA, Croatia) for 60 min in shaking water bath at 37°C. After this treatment 
15% ethanol (EtOH) were used for 5 min as toxic agent. The following procedures 
were the same as described above.
3.1.5. S ta tistics
Values in figures and text were expressed as means ± SEM. Comparisons 
were performed by unpaired Student's t test or by analysis of variance (ANOVA) 
followed by unpaired Student's t test. P values were considered significant at 
p<0.05.
38
3.2. RESULTS
3.2.1. Toxico log ica l studies
3.2.1.1. E ffect o f ethanol
5, 10, 15, 20 and 50% of EtOH concentration-dependently decreased the 
cell viability detected by TB exclusion test (Fig. 4). ECso = 13.5 %
Ethanol cc .  (%, v / v )
Fig. 4
Changes in the viability of acutely isolated gastric mucosal cells after 5 min 
incubation of 5-50% (v/v) ethanol detected by Trypan Blue exclusion test.
LDH activity concentration-dependently increased in the supernatant and at 
the same time it decreased in the cell pellet after ethanol treatment (Fig. 5). At high 
concentration of ethanol (50%) enzyme activity could not been detected because 
of inactivation.
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Fig. 5
LDH activity in the cell pellet and supernatant in freshly isolated rat gastric 
mucosal cells after 5 min incubation of 5-50% (v/v) ethanol.
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Fig. 6
EB-DNA fluorescence and SDH activity in freshly isolated rat gastric 
mucosal cells after 5 min 5-50% (v/v) ethanol treatment.
a) 4
01m
Ld
\/A  EB-DNA f luorescence 
(n = 6)
SDH ac t i v i t y
2 -
1 -
f t
/
/
/
/
f t
/
/
/
/
/
/
/
/
/
/
/
V
/
/
/
/
/
/
/
/
s
/
/
/
/
/
/
/
/
/
/
LAi
/
/
/
/
/
/
/
/
/LA f
o
rm
a
za
n
 
(n
m
o
l/
m
in
/2
x
 1 
0
6c
el
ls
)
40
SDH activity was concentration-dependently decreased parallel with the 
destruction of the cells. EB-DNA fluorescence was increased after ethanol 
treatment, it showed the nuclear damage of the cells (Fig. 6).
3.2.1.2. E ffect o f indom ethacin
After 5 min incubation of 1Cf8-10'3 M IND only the high doses (1Cf4-10‘3 M) of 
IND decreased significantly (p<0.01) the number of viable cells (Fig. 7).
Fig. 7
Changes in the viability of acutely isolated gastric mucosal cells after 5 min 
incubation of lO^-IO'3 M indomethacin (IND) detected by Trypan Blue 
exclusion test. * :  p<0.01 compared with untreated cells.
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3.2.1.3. Combined effect o f ethanol and indom ethacin
Using combined these toxic agents IND in all doses significantly (p<0.05, 
p<0.02, p<0.01) aggravated the 15% EtOH-induced cell injury determined by TB 
exclusion (Fig. 8). LDH activity in the cell pellet (Fig. 9) and SDH activity (Fig. 10) 
were decreased by combined treatment. LDH activity in the supernatant (Fig. 9) 
and EB-DNA fluorescence (Fig. 10) increased after 10"3 M IND plus 15 % EtOH 
treatment.
Fig. 8
Changes in the viability of acutely isolated gastric mucosal cells after 5 min 
incubation of 15% (v/v) ethanol (EtOH) and 10'8-10'3 M indomethacin (IND) 
detected by Trypan Blue exclusion test (% of control). * : p<0.05, ** : p<0.02, 
*** : p<0.01 compared with 15% EtOH treatment.
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Fig. 9
Lactate dehydrogenase activity in the cell pellet and supernatant of 106 
acutely isolated gastric mucosal cells after 5 min incubation of 15% (v/v) 
ethanol (EtOH) and 10'3 M indomethacin (IND). * : p < 0.05 compared with 
15% EtOH treatment.
Fig. 10
Quantity of formazan synthesized by succinic dehydrogenase in 2x106 
acutely isolated gastric mucosal cells and intensity of ethidium bromide-DNA 
fluorescence (arbitrary units) in 107 acutely isolated gastric mucosal cells 
after 5 min incubation of 15% (v/v) ethanol (EtOH) and 10'3 M indomethacin 
(IND).
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3.2.1.4. D irect ce llu la r effect o f H elicobacter py lo ri com bined w ith  15% 
ethanol
106-108 sonicated bacteria/ml had no direct cellular toxicity on freshly 
isolated rat GMCs. In addition it did not aggravate the 15% EtOH-induced cellular 
damage detected by Trypan Blue exclusion test (Fig. 11), LDH activity (Fig. 12) or 
ethidium bromide-DNA fluorescence (Fig. 13).
2.1.5. Com bined effect o f Helicobacter pylo ri and indom ethacin
30 min preincubation by sonicated H. pylori (106-108 bacteria) did not 
aggravate the lO^-IO '3 M IND-induced cell injury on freshly isolated rat GMCs 
detected as well as Trypan Blue exclusion test (Fig. 14) or SDH activity (Fig. 15).
Effect of 30 min incubation of sonicated 106-10s bacteria/ml H. pylori on the 
viability of freshly isolated rat gastric mucosal cells detected by Trypan Blue 
exclusion test without or with 5 min 15 % ethanol treatment.
Fig. 12
Changes in lactate dehydrogenase activity of freshly isolated rat gastric 
mucosal cells after 30 min incubation by sonicated H. pylori (106-108 
bacteria/ml) without or with 5 min 15 % ethanol (EtOH) treatment.
Fig. 13
Changes in ethidium bromide-DNA fluorescence of freshly isolated rat 
gastric mucosal cells after 30 min incubation by sonicated H. pylori (106-108 
bacteria/ml) without or with 5 min 15 % ethanol (EtOH) treatment.
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Fig. 14
Effect of lO^-IO'3 M indomethacin (IND) on the viability of freshly isolated rat 
gastric mucosal ceils detected by Trypan Blue exclusion test without or with 
30 min incubation by sonicated H. pylori (107 bacteria/ml).
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Fig. 15
Changes in succinic dehydrogenase activity of freshly isolated rat gastric 
mucosal cells after combined treatment of lO^-IO'3 M indomethacin (IND) 
and sonicated H. pylori (107 bacteria/ml).
3.2.2. Pharm acological and cytoprotective investigations
3.2.2.1. E ffect o f prostacyclin  preincubation
60 min preincubation of lO^-IO-4 M PGb did not prevent the 15% EtOH- 
induced cellular damage, but it significantly (p<0.05) protected the acutely isolated 
rat gastric mucosal cells against the combined effect of 10"3 M IND and 15 % EtOH 
detected by Trypan Blue exclusion test (Fig. 16). In the case of biochemical 
studies (SDH and LDH activity, EB-DNA fluorescence) these changes were not 
significant.
46
Fig. 16
Effect of 60 min incubation of 10'6-10'4 M PGI2 on freshly isolated rat GMCs 
detected by Trypan Blue exclusion test after 5 min 15% EtOH and 10'3 M 
IND treatment. *: p<0.05 (compared with 15% EtOH+10 3 M IND treatment).
3.2.2.2. E ffect o f histam ine
60 min preincubation by lO^-IO-6 M histamine did not cause any changes in 
the viability of rat GMCs. There was no measurable acid secretion in our 
incubating medium detected by phenol red indicator system. Combined with 5 min 
15% EtOH treatment 10-6 M histamine significantly (p<0.05) aggravated the EtOH- 
induced cellular damage detected by Trypan Blue exclusion test and SDH activity 
(Figs. 17, 18).
Fig. 17
Effect of 60 min incubation of 10'8-10'6 M histamine on the viability of freshly 
isolated rat gastric mucosal cells detected by Trypan Blue exclusion test 
without or with 5 min 15 % ethanol (EtOH) treatment. * : p<0.05 compared 
with 15% EtOH-treated control.
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Fig. 18
Changes in succinic dehydrogenase activity of freshly isolated rat gastric 
mucosal cells after 60 min incubation by 10'6-10"6 M histamine without or 
with 5 min 15 % ethanol (EtOH) treatment.
48
3.2.2.3. Combined e ffect o f histam ine and prostacyclin
60 min incubation of histamine in combination with 1C4 M PGb did not 
change the viability of freshly isolated rat GMCs detected by Trypan Blue 
exclusion (Fig. 19), but significantly (p<0.05) increased the 1 hr-survival of the 
cells detected by SDH activity (Fig. 20).
Fig. 19
Effect of 60 min incubation of 10"®-1 O'8 M histamine and 10"4 M PGI2 on the 
viability of freshly isolated rat gastric mucosal cells detected by Trypan Blue 
exclusion test without or with 5 min 15 % ethanol (EtOH) and 10'3 M 
indomethacin (IND) treatment. * : p<0.05, ** : p<0.02, *** : p<0.01 compared 
with PGI2 and EtOH treated control. + : p<0.05 compared with PGI2, EtOH 
and IND treated control.
3.2.2.4. Com bined effect o f histam ine, prostacyclin , ethanol and 
indom ethacin
60 min incubation of 10"®-1 O'6 M histamine combined with 10-4 M PGb 
significantly aggravated the 15% EtOH-induced cell injury detected by Trypan Blue 
exclusion test (Fig. 19). Surprisingly the lower doses of histamine caused higher
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cellular damage. SDH activity (showing the 1 hr-survival) did not suppose these 
negative changes (Fig. 20). The same tendency could be seen after combined 5 
min incubation of EtOH and IND: 10-8 M histamine significantly (p<0.05) 
aggravated the cell injury (Fig. 19), but this effect disappeared by SDH activity 
(Fig. 20).
—
"55o
o
x
CM\c
E\
o
Ec
co
No
E
L -
o
Fig. 20
Changes in succinic dehydrogenase activity of freshly isolated rat gastric 
mucosal cells after 60 min incubation of 10'6-! 0"8 M histamine and 10’4 M 
PGI2 without or with 5 min 15 % ethanol (EtOH) and 10'3 M indomethacin 
(IND) treatment. * :  p<0.05 compared with PGI2 treated control.
3.2.2.5. Pentagastrin
60 min preincubation of 10^-1 O'6 M pentagastrin did not cause any changes 
in the viability of GMCs. After 5 min incubation of 15% EtOH 10-4 M pentagastrin 
significantly (p<0.05) aggravated the EtOH-induced cellular damage (Fig. 21).
After 60 min incubation of 10'8-10'6-10'4 M pentagastrin combined with 10^ 
M PGb we also could not observe any protective effect against EtOH-induced cell 
injury (Fig. 21).
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Fig. 21
Changes in the viability of freshly isolated rat GMCs detected by Trypan 
Blue exclusion test after 60 min incubation of pentagastrin alone or 
combined with 10-4 M PGI2 and 5 min 15% EtOH treatment. *: p<0.05 
compared with 15% EtOH treated control.
3.2.2.6. PL-10 substances
3.2.2.6.1. PL 10.1.AK15-4 and PL 10.1.AK15-2
60 min incubation of these substances with rat gastric mucosal cells did not 
aggravate the EtOH-induced cell injury, however, we could not observed any 
protective effect against 15% EtOH tested by Trypan Blue exclusion test and SDH 
activity (Figs. 22, 23).
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There was a s ign ifican t ce llu la r protection detected by Trypan Blue 
exclusion test after 60 min incubation of 5 pg/ml dose of PL 10.1.15AK-3 against 
15% EtOH in rat GMCs (p<0.05, p=1.6417E-6 analyzed by ANOVA), but we could 
not observe it by SDH activity (Fig. 24).
2.2.6.2. PL 10.1.15AK-3
15% ETOH 5 50 500 n g / m l  5 / * g /m l
PL 1 0.1 .AK1 5 - 4
Fig. 22
Changes in the viability detected by Trypan Blue exclusion test and SDH 
activity of isolated rat gastric mucosal cells after 60 min incubation of PL 
10.1.AK15-4 and 5 min 15% ethanol (EtOH) treatment.
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155K ETOH 5 50 500 n g / m l  5 /ug /m l
PL 1 0.1 .AK1 5 - 2
Fig. 23.
Changes in the viability detected by Trypan Blue exclusion test and SDH 
activity of isolated rat gastric mucosal cells after 60 min incubation of PL 
10.1.15AK-2 and 5 min 15% ethanol (EtOH) treatment.
1 5 *  ETOH 500 n g /m l  5 / i g / m l
PL 10.1.1 5AK —3
Fig. 24
Changes in the viability and SDH activity of isolated rat gastric mucosal cells 
after 60 min incubation of PL 10.1.15AK-3 and 5 min 15% ethanol (EtOH) 
treatment. *: p<0.05 (15% EtOH vs. PL-10 preincubation+15% EtOH).
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We detected a sign ifican t and dose-dependent protection by Trypan 
Blue exclusion test in freshly isolated rat GMCs after 60 min incubation of PL
10.1.AK14-2 against 15% EtOH (p<0.001, p=1.4576E-6 analyzed by ANOVA). 
The biochemical examinations did not support these significant changes: we could 
detect only a protective tendency by SDH activity (Fig. 25).
This significant cytoprotection can be represent by the help of a dose-response 
curve: EDso=50 ng/ml, r=0.9982 (Fig. 26).
3.2.2.6.3. PL 10.1.AK14-2
COO
4—o
_ QO
’>
\/A  Trypan blue
(n = 8) * p < 0 -01
* *  p < 0 . 0 2
SDH act iv i ty  
(n = 4)
15 % ETOH 500 n g /m l  5 / i g / m l
PL 10.1 .AK1 4 — 2
Fig. 25
Changes in the viability detected by Trypan Blue exclusion test and SDH 
activity of rat gastric mucosal cells after 60 min incubation of PL 10.1.AK14- 
2 against 5 min 15% ethanol (EtOH) treatment. *: p<0.02 **: p<0.01 (15% 
EtOH vs. PL-10 preincubation+15% EtOH)
Fig. 26
Dose-response curve for PL 10.1.AK14-2 substance. The protection is 
expressed in percent values, the effect of 5 pg/ml dose was regarded as 
100% (Y=24.9X-1.8).
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4. LONG TERM CULTURES
4.1. MATERIALS AND METHODS
4.1.1. Standard continuous cell lines
4.1.1.1. Sp2/0-Ag14 cell line
Sp2/0-Ag14 (CRL 1581) is a non-secreting mouse myeloma cell line 
obtained from American Type Culture Collection (ATCC). These cells do not 
secrete any immunglobuline, in biological point of view they are internationally 
accepted as a general cell model (Schulman et al, 1978). Cells were cultured in 
Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum 
(FCS) and maintained in humidified incubator in 95% air and 5% CO2 at 37 °C.
4.1.1.2. Hep G2 cell line
Hep G2 (HB 8065) is a human hepatocellular carcinoma cell line obtained 
from American Type Culture Collection (ATCC). Cells are cultured in Dulbecco's 
modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS) and 
maintained in humidified incubator in 95% air and 5% CO2 at 37 °C.
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Fig. 27
Light microscopic visualization Sp2/0-Ag14 cells stained by the May 
Grunwald/Giemsa technique. The large cell is in the mitotic stage showing 
the intensive reproduction.
4.1.2. Toxicolog ica l studies
4.1.2.1. Ethanol
105 Sp2/0-Ag14 and Hep G2 cells were incubated with 1, 5, 10, 15 and 
20% of ethanol (EtOH) (Reanal, Budapest, Hungary) diluted in DMEM + 10% FCS 
for 5 min After this treatment cells were washed out and resuspended in the 
culture medium Viability was assessed by Trypan Blue exclusion test at 5 min, 60 
min, 4 hr and 24 hr after EtOH treatment.
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Pyrazole is an alcohol dehydrogenase enzyme inhibitor compound 
(Goldberg et Rydberg, 1969). During 1,5, 10, 15 and 20 % EtOH treatment and 24 
hr incubation 105 Sp2/0-Ag14 and Hep G2 cells were coincubated with 10'5 M 
pyrazole (Sigma Chemical Co., St. Louis, USA). Viability was determined by 
Trypan Blue exclusion test at 5 min, 60 min, 4 hr and 24 hr after EtOH treatment.
4.1.2.2. Pyrazole
4.1.2.3. Indom ethacin
Sp2/0-Ag14 cells were incubated with 10^-l 0"3 M doses of indomethacin 
(IND) (Chinoin, Hungary) for 5 min alone or in combination with 15% EtOH. Cell 
viability was determined by TB exclusion test immediately after the treatment.
4.1.3. Determ ination o f free radicals by electron spin resonance (ESR)-spin
trapping method
ESR measurements were carried out on a Bruker ESP300E spectrometer 
operating at X-band and equipped with 100 kHz field modulation. Free radicals 
were generated by a Fenton-type system consisting of ferrous complexes and 
hydrogen peroxide, using alpha-phenyl-N-tert-butylnitrone (PBN) as the spin trap. 
Spin trapping experiments were performed as follows: 150 mM PBN in water and 
untreated or EtOH-treated Sp2/0-Ag14 cell suspension (107/ml in DMEM without 
FCS) were mixed thoroughly. After addition of iron complexes (1 mM FeCh in 
0.0012 n HCI) and H2O2 (0.3 % stock solution, 8.8 mM), the sample was 
immediately injected into an ESR flat quartz cell. Typical time between mixing the 
reagents and the beginning of ESR signal acquisition was 1 min. Spectra were
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recorded at room temperature using 10 mW microwave power and 0.143 mT 
modulation amplitude. Measurements were carried out at 5, 60, 120, 180 and 240 
min after the 5 min EtOH-treatment. The presence of the spin adduct was detected 
by integrated spectra.
4.1.4. C ytoprotective investigations
4.1.4.1. Scavenger com pounds
105 Sp2/0-Ag14 cells were incubated with 15 % EtOH for 5 min, then cells 
were washed out. During and after EtOH incubation cells were coincubated with 
the following agents for 24 hr:
lO^-IO"3 M glutathione (GSH) (Sigma Chemical Co., St. Louis, USA)
10^-lO '3 M D-mannitol (Sigma Chemical Co., St. Louis, USA)
10"3 M dimethyl sulfoxide (DMSO) (Reanal, Budapest, Hungary) 
lO^-IO '3 M 5,5-dimethyl-1-pyrroline N-oxide (DMPO) (Sigma Chemical Co., 
St. Louis, USA)
4.1.4.2. PL-10 substances
Sp2/0-Ag14 cells were incubated by 5-50-500 ng/ml-5 pg/ml doses of four 
PL-10 substances (PL-10.1.AK15-2, PL-10.1.AK15-3, PL-10.1.AK15-4, PL-
10.1.AK14-2, for further information see chapter 3.1.4.4.) for 60 min, after it cells 
were treated by 15% EtOH for 5 min. Cell viability was determined by TB exclusion 
test and SDH activity immediately after EtOH treatment.
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4.1.5. Determ ination o f cell v iab ility
4.1.5.1. Trypan Blue exclusion test
See Chapter 3.1.2.1.
4.1.5.2. Succinic dehydrogenase assay
See Chapter 3.1.2.2.2.
4.1.5.3. Lactate dehydrogenase assay
See Chapter 3.1.2.2.1.
4.1.6. S ta tistics
Values in figures and text are expressed as means + SEM. Comparisons 
were performed by unpaired Student's t test. P values were considered significant 
at p<0.05.
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4.2. RESULTS
4.2.1. Toxico log ica l studies
4.2.1.1. D irect ce llu la r e ffect o f ethanol on Sp2/0-Ag14 cells
1, 5, 10, 15 and 20% EtOH concentration-dependently decreased the 
viability of Sp2/0-Ag14 cells (Fig. 28). There was no essential difference in cell 
viability between 5 and 60 min, while in 4 hr after EtOH treatment the cell 
destruction was increased at 15 % EtOH concentration. At 24 hr an expressive 
decrease began in the cell viability, which was significant at 15 % EtOH 
concentration (p<0.05 vs. control).
cc. EtOH (X )
Fig. 28
Effect of 5-min ethanol (EtOH) incubation on Sp2/0-Ag14 cells. Viability was 
detected by Trypan Blue exclusion test at 5, 60 min, 4 and 24 hr after EtOH 
exposure. *: p<0.05 vs. cell viability at the time of 5 min.
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4.2.1.2. D irect ce llu la r effect o f ethanol on Hep G2 cells
1, 5, 10 and 15% of EtOH concentration-dependently, but very slightly 
decreased the cell viability at the time of 5 min, 60 min, 4 hr and 24 hr. There was 
a great fall in the viability between 15 and 20% EtOH at all counting time (Fig. 29). 
Secondary cell destruction could not be seen in Hep G2 cells.
Fig. 29
Effect of 5-min ethanol (EtOH) incubation on Hep G2 cells. Viability was 
detected by Trypan Blue exclusion test at 5, 60 min, 4 and 24 hr after EtOH 
exposure.
4.2.1.3. E ffect o f pyrazole on EtOH-induced ce llu la r damage in Sp2/0-Ag14 
and Hep G2 cells
10"5 M pyrazole was not toxic for both types of cells. In Sp2/0-Ag14 cells 
there was no difference in the viability between 1, 5, 10, 15 and 20 % EtOH 
coincubated with 1C5 M pyrazole and only EtOH-treated cells (Fig. 30). The 
significant secondary cell destruction also could be seen in this model (p<0.05).
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In Hep G2 cells 10-5 M pyrazole aggravated the EtOH-induced cellular 
damage, the resistance against EtOH disappeared. At 10% EtOH a significant 
decrease was detectable in 24 hr after EtOH exposure, which show the same 
tendency like Sp2/0-Ag14 cells (Fig. 31).
Fig. 30
Effect of pyrazole on Sp2/0-Ag14 cells. After 5 min ethanol (EtOH) 
incubation cell viability was detected by Trypan Blue exclusion test at 5, 60 
min, 4 and 24 hr. During and after EtOH exposure cells were coincubated 
with 10'5 M pyrazole. *: p<0.05 vs. cell viability at the time of 5 min.
4.2.1.4. E ffect o f indom ethacin on Sp2/0-Ag14 cells
lO^-IO^M IND alone had no effect on the viability of Sp2/0-Ag14 cells. 
(Fig. 32).
Fig. 31
Effect of pyrazole on Hep G2 cells. After 5 min ethanol (EtOH) incubation 
cell viability was detected by Trypan Blue exclusion test at 5, 60 min, 4 and 
24 hr. During and after EtOH exposure cells were coincubated with 10'5 M 
pyrazole. *: p<0.05 vs. cell viability at the time of 5 min.
Fig. 32
Changes in the viability of Sp2/0-Ag14 cells after 5 min incubation of 10"8 - 
10'3 M indomethacin (IND) detected by Trypan Blue exclusion test.
64
4.2.1.5. Combined effect o f ethanol and indom ethacin on Sp2/0-Ag14 cells
Using combined these toxic agents 10-3 M IND significantly aggravated the 
15% EtOH-induced cell injury detected by Trypan Blue exclusion test, SDH and 
LDH activity (Figs. 33, 34).
Fig. 33
Changes in the viability of Sp2/0-Ag14 cells after 5 min incubation of 15% 
(v/v) ethanol (EtOH) and 10'3 M indomethacin (IND) detected by Trypan Blue 
exclusion test and SDH activity. *: p<0.01, +: p<0.05 compared with 15% 
EtOH treatment.
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Fig. 34.
Lactate dehydrogenase activity in the cell pellet and supernatant of 106 
Sp2/0-Ag14 cells after 5 min incubation of 15% (v/v) ethanol (EtOH) and 10'3 
M indomethacin (IND). *: p<0.05 compared with 15% EtOH treatment.
4.2.2. Free radical activ ity  in ethanol-induced ce llu la r damage in Sp2/0-Ag14 
cells
After EtOH-treatment the free radical activity was increased compared with 
untreated cells detected by ESR-spin trapping method (Fig. 35).
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A
B
Fig. 35
ESR spectra recorded 5 min after 15% ethanol (EtOH) exposure. (A) EtOH 
treated cells plus PBN in buffer solution. (B) Untreated cells plus PBN in 
buffer solution. (C) Buffer solution plus PBN.
67
The values of corrected double integral represent the following changes 
(Fig. 36):
a) The free radical activity showed a saturation curve both in untreated 
and EtOH-treated cells;
b) The EtOH treatment induced higher free radical activity during the 
measurement;
c) The free radical activity was increased immediately after the EtOH 
treatment.
Fig. 36
Curves representing the values of corrected double integral in control and 
ethanol (EtOH)-treated cells. After 5 min exposure of EtOH free radical 
activity was detected by ESR-spin trapping method at 5, 60, 120, 180 and 
240 min.
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4.2.3. C ytoprotective investigations
4.2.3.1. C ytoprotection induced by scavenger com pounds
1CT3 M DMPO and GSH significantly prevented the cells against 15% EtOH 
injury at the time of 4 hr (p<0.05), but this protection disappeared at 24 hr (Figs. 
37, 38). Coincubation of Sp2/0-Ag14 cells with 10'3 M DMSO significantly 
prevented the 15% EtOH-induced secondary cell destruction only at the time of 24 
hr (p<0.01). (Fig. 39). 10'3 M D-mannitol was not protective in this model. None of 
the examined compounds was toxic for the cells.
Fig. 37
Effect of 5,5-dimethyM-pyrroline N-oxide (DMPO) on Sp2/0-Ag14 cells. 
During and after 5 min exposure of 15 % ethanol (EtOH) cells were 
coincubated with 10'3 M DMPO, cell viability was detected by Trypan Blue 
exclusion test at 5, 60 min, 4 and 24 hr. * : p<0.05 compared with EtOH- 
treated cells.
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a f te r  5 min 15& ethanol  t re a tm e n t
Fig. 38
Effect of glutathione (GSH) on Sp2/0-Ag14 cells. During and after 5 min 
exposure of 15 % ethanol (EtOH) cells were coincubated with 10‘3 M GSH, 
cell viability was detected by Trypan Blue exclusion test at 5, 60 min, 4 and 
24 hr. * : p<0.05 compared with EtOH-treated cells.
a f te r  5 min 15% e thanol  t r e a tm e n t  
Fig. 39
Effect of dimethyl sulfoxide (DMSO) on Sp2/0-Ag14 cells. During and after 5 
min exposure of 15 % ethanol (EtOH) cells were coincubated with 10'3 M 
DMSO, ceil viability was detected by Trypan Blue exclusion test at 5, 60 min, 
4 and 24 hr. * : p<0.01 compared with EtOH-treated cells.
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4.2.3.2. D irect cytoprotective investigations by PL-10 substances
4.2.3.2.1. PL 10.1.AK15-4
60 min incubation of this substance with cultured mouse myeloma cells 
(Sp2/0-Ag14) did not aggravated the EtOH-induced cell injury, however, we could 
not observed any protective effect against 15% and 20% EtOH tested by Trypan 
Blue exclusion test (Fig. 40).
PL 1 0.1 .AK1 5 - 4
Fig. 40
Changes in the viability of Sp2/0-Ag14 cells after 60 min incubation of PL 
10.1.AK15-4 and 5 min 15% and 20% ethanol (EtOH) treatment.
4.2.3.2.2. PL 10.1.15AK-3 and PL 10.1.AK15-2
After 60 min incubation of these substances we could not observe any 
protective tendency against 5 min 15% EtOH treatment, and there were no 
changes in SDH activity (Fig. 41).
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4.2.3.2.3. PL 10.1.AK14-2
We could not detect any cytoprotection after 60 min incubation of PL
10.1.AK14-2 against 15% EtOH in Sp2/0-Ag14 cells by Trypan Blue exclusion test 
and SDH activity (Fig. 42).
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Fig. 41
Effect of 60 min incubation of PL 10.1.15AK-3 and PL 10.1.AK15-2 against 
15% ethanol (EtOH) on the viability of Sp2/0-Ag14 cells detected by Trypan 
Blue exclusion test.
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Fig. 42
Changes in the viability detected by Trypan Blue exclusion test and SDH 
activity of mouse myeloma cells (Sp2/0-Ag14) after 60 min incubation of PL 
10.1.AK14-2 against 5 min 15% ethanol (EtOH) treatment.
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5. DISCUSSION
The aim of this study was to evaluate the in vitro cytoprotective effect of 
some aggressive factors and in vivo organoprotective agents. These compounds 
were tested on short term (freshly isolated rat gastric mucosal cells) and long term 
(Sp2-0/Ag14 and Hep G2 cell line) cultures.
IN ORDER OF THE AIMS IT WAS FOUND THAT:
1) D irect short term  and long term  ce llu la r effect o f ethanol
Ethanol (EtOH) was applied as 5 min incubation on both cell culture 
models. EtOH concentration-dependently decreased the cell viability, but these 
results indicate that acutely isolated cells are more vulnerable than cultured cells. 
After EtOH treatment in the case of Sp2/0-Ag14 cells ECso was higher (16%) than 
in the case of GMC (13.5%). However, there are differences between the cell lines 
on dependent of their types: human hepatoma cell line (Hep G2) is more 
resistance against ethanol probably owing to its metabolic activity.
Immediately after 5 min incubation only the acute direct effect can be 
detected which is probably due to the lipide solvent property of EtOH. By the help 
of a long term cell culture model it is possible to analyze the later consequences of 
a relatively short-term EtOH treatment.
It was found that in 4 and 24 hr after EtOH treatment an unexpected 
secondary cell destruction could be detected at higher EtOH concentrations. 
Considering that this phenomenon manifested relatively later after EtOH treatment, 
it can be regarded as an oxygen free radicals mediated process. ESR-spin 
trapping detected an increased free radical activity in the cells after EtOH 
treatment.
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Regarding to these results oxygen free radicals play an important role in 
the long-term cell injury. This result is in agree with Cho et al. who observed an 
increased catalase activity 1 hr after EtOH treatment in vivo (Cho et al., 1992). 
They concluded that this high tissue level of catalase can prevent the oxygen free 
radicals mediated damage. We also could not detect any macroscopic (detected 
by trypan blue exclusion test) cell injury besides the direct effect of EtOH in the 
early phases, but our ESR study showed that the free radical activity in EtOH- 
treated cells increased immediately after EtOH exposure. The secondary cell 
destruction began relatively later (in 4 and mostly 24 hr), it seems that in the cells 
this time is necessary for the development of macroscopic damage.
2) D irect ce llu la r effect o f indom ethacin w ithou t o r w ith  application o f other 
aggressive factors
Indomethacin (IND) had no damaging effect on stable cultured cells, but its 
higher doses decreased the viability of isolated cells. The combined treatment with 
15% EtOH reduced the viability in both types of cells, but this effect was much 
milder in Sp2/0-Ag14 studies, while all the GMC were almost destroyed. These 
results also indicate that cultured cells are more resistant against toxic agents than 
acutely isolated cells. Though different types of cells were used in this study, 
nevertheless the differences in their behavior derive rather from the isolation 
procedure than their types.
In vivo experiments gastrointestinal ulceration can be produced by IND 
administration (Djahanguiri, 1969; Karadi et al., 1994). IND inhibits the activity of 
cyclo-oxygenase producing less amount of prostaglandins (PGs) and excessive 
vasoconstrictor leukotrienes (Rainsford, 1992). On the other hand, IND decreases 
the mucosal level of adenosine triphosphate (ATP) (Rainsford, 1987), so these 
factors reduce the gastric mucosal resistance against gastric acid. In our in vitro
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study when IND was applied without other aggressive factor such as EtOH, it was 
not toxic for the cells. But after combined treatment (IND plus EtOH) cell viability 
was considerably decreased compared to the effect of EtOH. Probably the 
decrease of the level of endogenous PGs might have a role in the enhanced toxic 
effect of EtOH. This result is in agreement with Tamawski et al. (Tamawski et al., 
1988) who observed a protective effect of exogenous PGs on human isolated 
gastric glands against IND and EtOH injury.
3) D irect ce llu la r e ffect o f the homogenate o f human pathogen 
H elicobacter pylori
In this study the direct cellular effect of sonicated H. pylori was examined 
on mixed population of freshly isolated rat gastric mucosal cells without and with 
other aggressive factors (EtOH and IND). This model is suitable to eliminate the 
additional effect of immune system, which is naturally involved in a bacterial 
infection. Due to sonication the possible toxic agents (e.g. toxins, unusual fatty 
acids, proteases) originated from destruction of bacteria can reach the cells in 
experimental circumstances.
It was found that sonicated H. pylori alone, or in combination with EtOH or 
IND did not have any direct cellular injury in freshly isolated rat gastric mucosal 
cells (Bodis et al., 1996b).
What can be the background of this result? There are a lot of data showing 
the very important role of tissue reactions (e.g. immune system) in the 
pathogenesis of H. pylori induced diseases. The bacterial supernatant contains 
novel chemotactic factors, mast cells are involved in immune mechanisms 
because of IgE response (Aceti et al., 1991). It is possible that IgE-mediated type I 
hypersensitivity reactions play a role in the production of gastric mucosal damage 
due to release of mast cell mediators (e.g. TNF, leukotrienes, PAF). Neutrophil 
activation is also involved in H. pylori infection: isolated surface proteins and
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chemotactic factors from bacterial supernatant can induce it. The produced oxygen 
radicals can be toxic for gastrointestinal mucosa (Chadwick, 1994). Whether these 
immune responses are primary or consequent to the development of gastritis 
remains to be established.
One of the other possible explanations is that H. pylori can be a facultative 
microorganism. Regarding to the very high infectious rate in the population, this 
bacterium might be only simply an opportunist. However, in the presence of a 
mucosal lesion it might be a pathogenic factor for gastrointestinal diseases.
4) The prostacyclin-induced direct cytoprotection against ethanol- and 
indom ethacin in jury
In this study the in vitro cytoprotective effect of prostacyclin (PGb) was 
analyzed on mixed population of freshly isolated rat GMCs. After preincubation of 
10^-10"4 M PGb it could not be found any cytoprotective effect against EtOH injury, 
but there was a significant cell protection after IND plus EtOH treatment detected 
by Trypan Blue exclusion test (Bodis et al., 1995).
It is known that PGb has a good cytoprotective effect in vivo against EtOH- 
induced gastric mucosal damage, and this effect disappears after acute bilateral 
surgical vagotomy (Mozsik et al., 1991a). The cytoprotective effect of PGb 
manifests in the early phase after administration of the necrotizing agent (Suto et 
al., 1989), according to Szabo et al. this is the phase of the early vascular and 
mucosal injury (Szabo et al., 1985). Regarding to these facts it is not surprise that 
without these protective factors (vagal nerve and blood flow) PGI2 has no direct 
cytoprotective effect against EtOH-induced cellular damage.
However, exogenous PGb was able to significantly reduce in vitro the 
aggravating effect of IND. In animal experimental studies PGb was also found to 
be cytoprotective against IND-induced mucosal injury (Garamszegi et al., 1984).
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The main action of IND is inhibiting cyclooxigenase enzyme activity and by this 
way decreasing the synthesis of prostaglandins (Vane, 1971). It seems that 
exogenous PGb also has cytoprotective effect against IND at cellular level.
5) D irect ce llu la r e ffect o f histam ine and pentagastrin
In this study the cytoprotective effects of histamine and pentagastrin were 
analyzed on isolated rat gastric mucosal cells.
These results indicated that:
1) Histamine alone did not influence the viability of the cells, but after 
coincubation with PGb it significantly increased the 1 hr-survival time detected 
by SDH activity without any aggressive factor;
2) Histamine pretreatment significantly aggravated the 15% EtOH-induced cell 
injury;
3) Histamine combined with PGb also significantly aggravated the EtOH-induced 
and EtOH+IND-induced cellular damage detected by Trypan Blue exclusion 
test, but this significant changes disappeared after 1 hr detected by SDH 
activity (Bodis et al., 1996a).
It is known that surprisingly both gastric acid secretion inhibiting and 
stimulating drugs can prevent the EtOH-induced mucosal damage in vivo (Mozsik 
et al., 1988). Furthermore, it was proved that the intact vagus is basically 
necessary for the receiving gastric cyto- and mucosal protection by atropine, 
cimetidine, PGb and (3-carotene (Mozsik et al., 1995). The inhibitory drugs such as 
cimetidine and atropine decrease the cell metabolism, while pentagastrin, 
histamine and 2,4-dinitrophenol (for a short time) increase it. The PGh-induced 
gastric cytoprotection is decreased by gastric acid inhibitory drugs, however, 
histamine, pentagastrin and 2,4-dinitrophenol can stimulate it. This effect partly 
can be explained by acting at the level of receptors due to reduction of ATP-ADP 
transformation and increasing the cellular cAMP content (in the case of histamine
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and pentagastrin) (M6zsik et al., 1988), but the mechanism of 2,4-dinitrophenol is 
quite different (inhibition the respiratory chain). W ith this knowledge of the facts 
metabolic components have to play a role in the protection of gastric mucosal 
damage.
In vitro circumstances we could not detect any cytoprotective effect of 
histamine alone or in combination with PGb. However, the preincubation of these 
drugs increased the survival of the cells and could reduce the long-term cell injury. 
These results show that histamine alone or combined with PGb might stimulate the 
metabolism of isolated cells which can be detected by SDH activity, but this effect 
is not enough for the development of cytoprotection (other in vivo factors e.g. vagal 
nerve are also necessary).
Regarding to these in vivo and in vitro studies the organo- and 
cytoprotective effect of histamine seems to be different in rats.
The possible cytoprotective effect of pentagastrin was tested on freshly 
isolated rat gastric mucosal cells.
It was found that:
1) pentagastrin preincubation significantly aggravated the 15% EtOH-induced cell 
injury;
2) After PGb and pentagastrin treatment also could not been observed any 
cytoprotective effect against EtOH-induced cellular damage, but the significant 
aggravating effect of pentagastrin is disappeared (Bodis et al., 1997c).
In vivo pentagastrin has the same cytoprotective and biochemical effect like 
histamine. These in vitro results also showed similar tendency like histamine, it 
seems that the background of the effect of these two aggressive factors is based 
on the same physiological and biochemical processes.
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6) C ytoprotection induced by PL-10 substances (synthesized parts o f BPC)
PL-10 substances are the synthesized variants of the originally described 
pentadecapeptide BPC 157 (Sikiric et al., 1993a). In this study the in vitro effect of 
PL-10 substances was evaluated on freshly isolated rat gastric mucosal cells and 
on cultured mouse myeloma cell line (Sp2/0-Ag14). After 60 min incubation of 
these substances (5-50-500 ng/ml-5 pg/ml) we treated the cells by ethanol (15%) 
to detect the direct cytoprotective effect.
It was found-that:
1. PL-10 substances were not toxic for freshly isolated rat GMCs and mouse 
myeloma cells;
2. PL 10.1.AK14-2 showed a dose-dependent and very significant (p<0.01 
and p<0.02) direct cytoprotective effect in doses of 50 - 500 ng/ml - 5 pg/ml 
on freshly isolated rat gastric mucosal cells. EDso=50 ng/ml, r=0.9982;
3. PL 10.1.15AK-3 was significantly (p<0.05) cytoprotective in dose of 5 pg/ml 
on freshly isolated rat gastric mucosal cells;
4. These substances were not effective on cultured mouse myeloma cells.
These results show that PL-10.1.15AK-3 and PL 10.1.AK14-2 substances 
can protect the freshly isolated rat gastric mucosal cells against ethanol injury. 
This direct cytoprotective effect is stronger and dose-dependent in the case of PL 
10.1 .AK14-2 substance (EDso=50 ng/ml). This effect is very quick after exposure of 
the necrotizing agent, because it could not been observed by SDH activity - the 
duration of this measurement is 1 hr, indirectly it shows the survival of the cells, 
while Trypan Blue exclusion test reflects the viability immediately after the 
treatment (Bodisetal., 1997d).
Because it could not been observed any cytoprotection on cultured mouse 
myeloma cells, it seems that this cellular protection is a specific action for healthy 
gastrointestinal cells.
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Although the exact mechanism of the BPC-induced huge range 
organoprotection is yet unknown, it seems that systematic processes (e.g. 
hormonal system (Sikiric et al., 1992) and Selye's general-adaptive-syndrome 
(Sikiric et al., 1993a) play an important role in the development of this 
phenomenon. The fact that in vivo BPC 157 is also effective in the rat stomach 
when given simultaneously with ethanol (M6zsik et al., 1991b) shows a very strong 
organoprotective and a direct cellular protection. The newly synthesized PL-10 
substances (originated from BPC) also show this organoprotection in animal 
experiments (Erceg et al., 1997), and two of them proved to be cytoprotective in 
this in vitro study. By this way this study supported the hypothesis of the existence 
of direct cellular protection and it gave further evidence for the exact mechanism of 
the BPC-induced beneficial effects.
7) The effect o f scavengers in long term  cell in ju ry
The effect of scavengers (DMPO, GSH, DMSO and D-mannitol) was 
analyzed on the free radical-induced secondary cell destruction (detected by ESR- 
spin trapping) on Sp2/0-Ag14 cell line. The most important in vivo agent beta- 
carotene cannot be applied in vitro circumstances because of its lipid solubility 
property.
It was found that GSH and DMPO could prevent the free radicals-induced 
cell destruction at 4 hr, DMSO was found to be cytoprotective in 24 hr after EtOH 
exposure, while D-mannitol was ineffective in this model (Bodis et al., 1997a).
Based on these ESR studies, the free radical activity increased immediately 
after EtOH administration, but it manifested in the decrease of cell viability 
relatively later, in 4 and 24 hr. GSH and DMPO are not stable molecules in 
biological systems, their scavenger effects manifested significantly only in the first 
period. DMSO is a generally used cellular protective agent (e.g. preservation of
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the cells by freeze), in addition it is a good hydroxyl radical scavenger (Del 
Maestro et al., 1980). The major oxygen radical responsible for the EtOH-induced 
cellular damage is the hydroxyl radical (Mutoh et al., 1990). Previously GSH and 
DMSO were found to be protective in EtOH-induced cellular damage but 
immediately after the necrotizing agent (Mutoh et al., 1989). This study gave 
further information about the dynamics of free radical activity after EtOH injury.
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6. CONCLUSIONS
THE NEW RESULTS OF THIS DISSERTATION ARE:
•  It was proved by the help of long term cell cultures that there are two main factors
in the direct cellular effect of ethanol: a chemical action and an ethanol- 
induced free radical activity causing secondary cell destruction. In addition, an 
ESR-spin trapping study was performed in the cell suspension;
• Indomethacin without other aggressive factor do not induce cellular damage, but
in the presence of ethanol it aggravates the cell destruction;
• Human pathogen Helicobacter pylori do not have strictly direct cytotoxic effect, in
addition, it do not aggravates the other aggressive factor-induced cellular 
damage;
• The organoprotection induced by prostacyclin have no direct cytoprotective
component;
• The histamine- and pentagastrin-induced organoprotection is not presented at
cellular level;
• It was proved that in the general beneficial effect of BPC a direct cytoprotection
plays an important role;
• A part of the effect of scavengers is a direct cytoprotection, which can be
manifested in different time after ethanol exposure on dependence of their 
chemical structure.
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Accord ing to  these results on ly a few  in v ivo  "cytopro tective" 
com pounds have d irect ce llu la r protection. M ost o f these agents have other 
system atic (e.g. vascular, neuronal and horm onal) effect, w hich influence the  
developm ent o f the protection. The m echanism s o f organo- and 
cytoprotection d iffe r from  each other - d irect cytoprotection takes on ly a part 
in the phenomenon o f organoprotection.
Advantages o f these m ethods fo r possib le c lin ica l perspectives
• By the help of these experimental methods the com plex physio logica l 
m echanism s can be examined at cellular level.
• The tox ic  effect of different drugs can also be evaluated at the level of the 
cells.
• The scavenger property of further agents can be estimated in the long term 
cell culture models.
• These kinds of experiments (cell isolation and cell cultures) are acceptable fo r 
anim al experim ental ethical requirements.
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